Sign up to save your podcasts
Or
Share Before The Show #80 - Paragraph IV Patent Litigation in the 2019 Landscape
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Before The Show #80 - Paragraph IV Patent Litigation in the 2019 Landscape
* Use coupon code PODCAST25 for 25% off this webcast *
Webcast URL: https://www.theknowledgegroup.org/webcasts/paragraph-iv-patent-certifications-2/
Join us for this Knowledge Group Online CLE Paragraph IV Webinar. In recent years, generic drug manufacturers have been grappling with filing Paragraph IV (PIV) challenges to successfully gain market entry. The significant increase in the number of patent challenges on brand drugs, specifically on blockbuster drugs, is expected to continue in 2019. However, with the evolving regulatory paradigm, manufacturers become vulnerable to a myriad of risks, including the likelihood of a PIV lawsuit.
In the changing PIV landscape, it is imperative that pharmaceutical companies are abreast of the latest developments to avoid patent infringement, more so, the complexities of a PIV litigation. They must be well-versed with the litigation know-hows to efficiently and effectively win a PIV dispute.
Listen as a panel of distinguished professionals and thought leaders assembled by The Knowledge Group provide an in-depth discussion of the significant trends and developments in Paragraph IV Patent Litigation. Speakers will also offer best strategies that will help manufacturers and counsel in this evolving landscape.
For anymore information please click on the webcast url at the top of this description.
View all episodes
By The Knowledge Group
5
33 ratings
* Use coupon code PODCAST25 for 25% off this webcast *
Webcast URL: https://www.theknowledgegroup.org/webcasts/paragraph-iv-patent-certifications-2/
Join us for this Knowledge Group Online CLE Paragraph IV Webinar. In recent years, generic drug manufacturers have been grappling with filing Paragraph IV (PIV) challenges to successfully gain market entry. The significant increase in the number of patent challenges on brand drugs, specifically on blockbuster drugs, is expected to continue in 2019. However, with the evolving regulatory paradigm, manufacturers become vulnerable to a myriad of risks, including the likelihood of a PIV lawsuit.
In the changing PIV landscape, it is imperative that pharmaceutical companies are abreast of the latest developments to avoid patent infringement, more so, the complexities of a PIV litigation. They must be well-versed with the litigation know-hows to efficiently and effectively win a PIV dispute.
Listen as a panel of distinguished professionals and thought leaders assembled by The Knowledge Group provide an in-depth discussion of the significant trends and developments in Paragraph IV Patent Litigation. Speakers will also offer best strategies that will help manufacturers and counsel in this evolving landscape.
For anymore information please click on the webcast url at the top of this description.